KLTO - Klotho Neurosciences Inc.


0.166
-0.014   -8.434%

Share volume: 230,716
Last Updated: 05-07-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: -0.02%

PREVIOUS CLOSE
CHG
CHG%

$0.18
-0.01
-0.08%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024
Report Date 05-23-2024 08-19-2024 11-19-2024
Total revenue 0.000 0.000 0.000
Cost of revenue 0.000 0.000 0.000
Gross profit 0.000 0.000 0.000
    nan% nan%  
Operating expenses 324.777 K 395.607 K 2.871 M
Selling general and admin 324.777 K 395.607 K 2.871 M
Research and development 0.000 0.000 0.000
Total expenses 342.777 K 395.607 K 2.871 M
    15.41% 625.70%  
Operating income -342.777 K -395.607 K -2.871 M
Ebit -325.817 K -436.575 K -2.914 M
Pretax income -74.154 K -451.639 K -2.959 M
    509.06% 555.26%  
Income tax 49.069 K 0.000 0.000
Net income basic 0.000 0.000 0.000
         
Net income -123.223 K -451.639 K -2.959 M
    -266.52% -555.26%